SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-263791
Filing Date
2019-10-07
Accepted
2019-10-07 16:42:36
Documents
3
Period of Report
2019-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d838448d8k.htm 8-K 20858
2 EX-10.1 d838448dex101.htm EX-10.1 81486
3 EX-10.2 d838448dex102.htm EX-10.2 72263
  Complete submission text file 0001193125-19-263791.txt   175945
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 191141242
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences